In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y

Ali A Taleb; Robert G Badgett

doi:10.7326/ACPJ202110190-115

In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y

Ann Intern Med. 2021 Oct;174(10):JC115. doi: 10.7326/ACPJ202110190-115. Epub 2021 Oct 5.

Authors

Ali A Taleb¹, Robert G Badgett¹

Affiliation

¹ University of Kansas School of Medicine, Wichita, Kansas, USA (A.A.T., R.G.B.).

PMID: 34606305
DOI: 10.7326/ACPJ202110190-115

Abstract

Menzies-Gow A, Corren J, Bourdin A, et al. Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med. 2021;384:1800-9. 33979488.

Publication types

Comment

MeSH terms

Adolescent
Adult
Anti-Asthmatic Agents* / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Asthma* / drug therapy
Double-Blind Method
Humans

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
tezepelumab